Table 1 Conjugate addition of radicals derived from diacyloxyiodo-
benzenes with dehydroamino acids
Dehydro-
amino acid
Diacyloxy-
iodobenzene
Entrya
1
Product (yield)
3
3
5
6
10 (44 %)
2
3
Scheme 3 Reagents and conditions: i, [(COD)Rh((R,R)-Et-DuPHOS)]BF4,
MeOH, 100 psi, H2, 59%; ii, Boc2O, NEt3, DMAP, CH2Cl2, 95%; iii, LiOH,
MeOH, H2O, 59%.
(54 %)
3
3
This procedure, as well as removing the trityl protecting group,
gives the meso-DAP derivative 11 in a 9+1 mixture of
diastereomers (by 1H NMR spectroscopy). This fortuitous result
obviously allows selective manipulation at this stage of one of
the amino groups. To show orthogonality of the carboxy
functions, the amino group was re-protected with Boc2O and
then treated with one equivalent of lithium hydroxide. This led
to the hydrolysis of predominantly the methyl ester to give the
mono-acid 12 in 59% yield.
9
7
(44 %)
(32 %)
4
5
In summary, thermolysis of glutamate-derived iodobenzenes
leads to primary radicals which can be captured by dehy-
droamino acids by conjugate addition. In contrast to related
systems,12 the newly formed secondary radical, is not reduced
by 1,4-cyclohexadiene or other hydrogen atom donors, resulting
in production of unsaturated adducts and dimerisation products.
Chiral hydrogenation of an unsaturated derivative gives se-
lectively-protected DAP. Orthogonality of protection has also
been demonstrated.
3
4
8
(35 %)
Financial support from the Alberta Heritage Foundation for
Medical Research (Fellowship to A. S.), the Natural Sciences
and Engineering Research Council of Canada and the Canada
Research Chair in Bioorganic and Medicinal Chemistry (to
J. C. V.) is gratefully acknowledged.
6
8
(35 %)
a All reactions were carried out using 1,4-cyclohexadiene (5.0 equiv.) in
benzene under reflux for 12 h.
Notes and references
1 T. D. H. Bugg and C. T. Walsh, Nat. Prod. Rep., 1992, 9, 199; J. Van
Heijenoort, Nat. Prod. Rep., 2001, 18, 503.
stereochemistry of these dimerisation products either by NMR
spectroscopy or X-ray crystallography were unsuccessful.
However, it is likely that after conjugate addition, dimerisation
takes place from the least hindered face of the oxazolidinone
ring to give the dimerisation products with absolute ster-
eochemistry as shown in Table 1. These intriguing results
suggest that the conjugate adduct radical while not accessible
enough to abstract a hydrogen atom from 1,4-cyclohexadiene
can still undergo dimerisation. It should be noted that none of
the unsaturated adducts were isolated from either of these two
reactions. Entry 5 was also repeated under photolytic conditions
using a high pressure mercury lamp as the source of irradiation.
However, as with the thermolysis conditions, only the dimerisa-
tion product was isolated (25% yield). In a further series of
experiments other sources of hydrogen donors were studied.
Entry 5 was repeated using tributyltin hydride, trimethyl
orthoformate or triethylsilane under thermolysis conditions.12
These reactions gave very complex mixtures of products, with
neither the dimers nor the unsaturated derivatives being
produced in isolable amounts.
Due to the inability of this approach to directly produce the
saturated skeleton of DAP, we examined reduction of an
unsaturated derivative to give the desired selectively-protected
skeleton. Stereoselective hydrogenation of unsaturated pro-
tected DAP skeletons to make DAP isomers is well pre-
cedented.4,13 Therefore, the unsaturated derivative 10 was
hydrogenated with [(COD)Rh((R,R)-Et-DuPHOS)]BF4 using
the conditions described by Burk and co-workers (Scheme 3).14
2 R. J. Cox, Nat. Prod. Rep., 1996, 13, 29; G. Scapin and J. S. Blanchard,
Adv. Enzymol. Relat. Areas Mol. Biol., 1998, 72, 279; R. J. Cox, A.
Sutherland and J. C. Vederas, Bioorg. Med. Chem., 2000, 8, 843.
3 For some recent syntheses of DAP and its analogues see: F. A. Davis
and V. Srirajan, J. Org. Chem., 2000, 65, 3248; B. T. Shireman and M.
J. Miller, J. Org. Chem., 2001, 66, 4809; J. F. Caplan, A. Sutherland and
J. C. Vederas, J. Chem. Soc., Perkin Trans. 1, 2001, 2217.
4 P. N. Collier, I. Patel and R. J. K. Taylor, Tetrahedron Lett., 2001, 42,
5953.
5 S. Izumi, K. Nakahara, T. Gotoh, S. Hashimoto, T. Kino, M. Okahara,
H. Aoki and H. Imanaka, J. Antibiot., 1983, 36, 566; K. E. Luker, J. L.
Collier, E. W. Kolodziej, G. R. Marshall and W. E. Goldman, Proc.
Natl. Acad. Sci. U.S.A., 1993, 90, 2365.
6 A. L. J. Beckwith and C. L. L. Chai, Chem. Commun., 1990, 1087; J. R.
Axon and A. L. J. Beckwith, J. Chem. Soc., Chem. Commun., 1995,
549.
7 R. C. F. Jones, D. J. C. Berthelot and J. N. Iley, Chem. Commun., 2001,
2131.
8 For a review of intramolecular radical conjugate addition see: W.
Zhang, Tetrahedron, 2001, 57, 7237.
9 E. B. Merkushev, A. N. Novikov, S. S. Makarchenko, A. S.
Moskalchuk, V. V. Glushkova, T. I. Kogai and L. G. Polyakova, J. Org.
Chem. (U.S.S.R.), 1975, 1246.
10 G. A. Flynn and D. W. Beight, Tetrahedron Lett., 1984, 25, 2655.
11 R. M. Williams and G. J. Fegley, J. Am. Chem. Soc., 1991, 113,
8796.
12 H. Togo, M. Aoki and M. Yokoyama, Tetrahedron, 1993, 49, 8241.
13 R. C. Holcomb, S. Schow, S. Ayral-Kaloustian and D. Powell,
Tetrahedron Lett., 1994, 35, 7005.
14 M. J. Burk, J. E. Feaster, W. A. Nugent and R. L. Harlow, J. Am. Chem.
Soc., 1993, 115, 10 125.
CHEM. COMMUN., 2002, 224–225
225